Nureca Ltd

₹ 247 -3.32%

28 Feb - close price

About

Incorporated in 2016, Nureca Ltd is in the business of home healthcare and wellness products^[1]

Key Points

Business Overview:^[1]
Nureca Limited operates as a digital-first healthcare company with a diverse and innovative portfolio catering to the home healthcare and wellness segment. The company is recognized for its flagship brand Dr Trust and focuses on delivering high-quality, accessible, and technology-driven solutions to customers.

Website BSE NSE - BE

Market Cap ₹ 247 Cr.
Current Price ₹ 247
High / Low ₹ 448 / 240
Stock P/E
Book Value ₹ 193
Dividend Yield 0.00 %
ROCE -1.19 %
ROE -1.12 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Company has low interest coverage ratio.
Company has a low return on equity of 5.98% over last 3 years.
Promoter holding has decreased over last 3 years: -5.94%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: E-Commerce/App based Aggregator Industry: Trading

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	48.08	41.08	26.06	36.79	27.84	21.22	21.23	31.35	22.37	19.56	23.31	32.37	27.21
	42.89	43.61	31.56	41.63	29.08	25.03	24.22	30.31	26.80	24.32	26.23	35.03	31.95
Operating Profit	5.19	-2.53	-5.50	-4.84	-1.24	-3.81	-2.99	1.04	-4.43	-4.76	-2.92	-2.66	-4.74
OPM %	10.79%	-6.16%	-21.11%	-13.16%	-4.45%	-17.95%	-14.08%	3.32%	-19.80%	-24.34%	-12.53%	-8.22%	-17.42%
	1.75	1.71	1.18	1.91	1.92	2.15	2.69	3.21	5.92	-1.25	5.82	3.21	1.52
Interest	0.11	0.28	0.13	0.10	0.10	0.10	0.11	0.08	0.10	0.17	0.13	0.25	0.14
Depreciation	0.41	0.57	0.59	0.60	0.58	0.54	0.56	0.56	0.56	0.56	0.61	0.57	0.49
Profit before tax	6.42	-1.67	-5.04	-3.63	0.00	-2.30	-0.97	3.61	0.83	-6.74	2.16	-0.27	-3.85
Tax %	24.77%	-29.94%	-23.21%	-23.14%		-21.74%	-22.68%	26.87%	90.36%	-34.57%	44.91%	140.74%	-14.55%
	4.84	-1.17	-3.87	-2.78	0.03	-1.80	-0.74	2.64	0.08	-4.41	1.20	-0.65	-3.29
EPS in Rs	4.84	-1.17	-3.87	-2.78	0.03	-1.80	-0.74	2.64	0.08	-4.41	1.20	-0.65	-3.29
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017 5m	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	0	1	1	99	213	256	112	95	102
	0	1	1	90	152	200	127	105	118
Operating Profit	0	0	0	10	62	56	-15	-11	-15
OPM %	0%	3%	4%	10%	29%	22%	-14%	-11%	-15%
	0	0	0	0	3	8	7	10	9
Interest	0	0	0	1	2	1	0	0	1
Depreciation	0	0	0	0	0	1	2	2	2
Profit before tax	0	0	0	9	62	61	-11	-3	-9
Tax %		50%	33%	26%	26%	26%	-23%	-25%
	0	0	0	6	47	45	-8	-2	-7
EPS in Rs	0.00	20.00	20.00	6,410.00	46.53	45.31	-8.42	-2.44	-7.15
Dividend Payout %		0%	0%	0%	4%	7%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	165%
3 Years:	-24%
TTM:	7%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-4072%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	-44%
1 Year:	-27%

Return on Equity
10 Years:	%
5 Years:	13%
3 Years:	6%
Last Year:	-1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.01	0.01	0.01	0.01	10	10	10	10	10
Reserves	0	0	0	15	153	194	185	183	183
	0	0	0	10	4	4	3	2	4
	0	0	1	9	19	11	8	9	13
Total Liabilities	0	0	1	34	186	220	207	204	211
	0	0	0	1	3	10	8	6	8
CWIP	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	1	34	62	97	3
	0	0	1	33	181	175	136	101	200
Total Assets	0	0	1	34	186	220	207	204	211

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-0	-8	35	2	12	-3
	0	-0	-110	-3	-18	18
	0	8	92	-7	-2	-1
Net Cash Flow	0	-0	17	-9	-8	14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	365	87	65	47	0	4	14	7
Inventory Days	0	101	590	93	135	174	154	156
Days Payable		233	849	33	32	13	23	27
Cash Conversion Cycle	365	-45	-195	107	103	165	145	136
Working Capital Days	182	-12	-45	85	62	110	152	163
ROCE %		100%	75%	76%	67%	33%	-5%	-1%

Shareholding Pattern

Numbers in percentages

17 Recently

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	70.00%	70.00%	70.00%	62.98%	62.98%	62.98%	63.24%	63.24%	63.24%	63.24%	63.78%	64.06%
	12.22%	12.04%	1.67%	0.10%	0.10%	0.10%	0.10%	0.07%	0.07%	0.07%	0.69%	0.36%
	5.23%	5.22%	0.55%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%
	12.55%	12.74%	27.78%	36.92%	36.91%	36.92%	36.67%	36.69%	36.69%	36.69%	35.53%	35.54%
No. of Shareholders	26,123	26,114	63,911	62,007	58,560	55,569	52,255	49,600	45,996	43,813	41,986	41,314

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Dec 2024
	70.00%	70.00%	62.98%	63.24%	64.06%
	10.51%	12.22%	0.10%	0.07%	0.36%
	8.09%	5.23%	0.00%	0.00%	0.04%
	11.40%	12.55%	36.91%	36.69%	35.54%
No. of Shareholders	7,827	26,123	58,560	45,996	41,314

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Jan 2025

Transcript

Notes
PPT
Oct 2024

Transcript

Notes
PPT
Aug 2024

Transcript

Notes
PPT
May 2024

Transcript

Notes
PPT
Feb 2024

Transcript

Notes
PPT
Nov 2023

Transcript

Notes
PPT
Aug 2023

Transcript

Notes
PPT